Pages that link to "Q44434565"
Jump to navigation
Jump to search
The following pages link to Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia (Q44434565):
Displaying 50 items.
- Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA. (Q24810521) (← links)
- Cancer-treatment-induced neurotoxicity--focus on newer treatments (Q26782604) (← links)
- Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis (Q26795604) (← links)
- PPAR-γ -- a possible drug target for complicated pregnancies (Q26863678) (← links)
- Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic Diseases (Q28078222) (← links)
- Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis (Q28195758) (← links)
- Pathophysiology and medical management of systemic hypertension in preeclampsia (Q28208736) (← links)
- Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia (Q30479679) (← links)
- Neuroimaging in posterior reversible encephalopathy syndrome (Q30923275) (← links)
- Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease (Q31021082) (← links)
- Association between abnormal uterine artery Doppler flow velocimetry, risk of preeclampsia, and indices of arterial structure and function: a pilot study (Q33337837) (← links)
- Molecular mechanisms of preeclampsia (Q33344105) (← links)
- Headache and hypertension. Myth and evidence (Q33564541) (← links)
- Microvascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators (Q33612318) (← links)
- The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia (Q33668328) (← links)
- Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: The ABCD study (Q33707907) (← links)
- Autonomic circulatory control during pregnancy in humans (Q33762529) (← links)
- Vascular and cellular calcium in normal and hypertensive pregnancy (Q33781354) (← links)
- Maternal Arterial Stiffness in Women Who Subsequently Develop Pre-Eclampsia (Q33894709) (← links)
- Pathological aspects of lipid peroxidation. (Q34137628) (← links)
- Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. (Q34428654) (← links)
- Increased microvascular vasodilation and cardiovascular risk following a pre-eclamptic pregnancy (Q34631972) (← links)
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis (Q34708320) (← links)
- The Role of Obesity in Preeclampsia (Q34853745) (← links)
- Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate (Q34983609) (← links)
- Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial (Q35002508) (← links)
- Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome. (Q35016382) (← links)
- Flow-mediated dilation: can new approaches provide greater mechanistic insight into vascular dysfunction in preeclampsia and other diseases? (Q35073775) (← links)
- Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. (Q35090446) (← links)
- Prediction of early and late preeclampsia by flow-mediated dilation of the brachial artery (Q35109763) (← links)
- Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy (Q35171193) (← links)
- First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia (Q35532857) (← links)
- Pathophysiology of pre-eclampsia: Update on the role of nitric oxide (Q35574183) (← links)
- Pregnancy: a stress test for life (Q35587249) (← links)
- Challenges posed to the maternal circulation by pregnancy (Q35602490) (← links)
- Prevention of vascular dysfunction after preeclampsia: a potential long-term outcome measure and an emerging goal for treatment (Q35607434) (← links)
- Flow-mediated vasodilation is not attenuated in hypertensive pregnancies despite biochemical signs of inflammation (Q35825283) (← links)
- Fetal growth is associated with first-trimester maternal vascular function (Q35896255) (← links)
- The Use of l-Arginine in the Management of Pre-Eclampsia and Intrauterine Growth Restriction (Q36006037) (← links)
- Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule (Q36018553) (← links)
- Nitric oxide and blood: a review (Q36043081) (← links)
- Comparative Study of Endothelial Function and Uterine Artery Doppler Velocimetry between Pregnant Women with or without Preeclampsia Development (Q36132172) (← links)
- Pregnancy increases myometrial artery myogenic tone via NOS- or COX-independent mechanisms (Q36178537) (← links)
- Angiogenic factors in the pathogenesis of preeclampsia (Q36339288) (← links)
- Impaired neurovascular reactivity in the microvasculature of pregnant women with preeclampsia. (Q36381293) (← links)
- Cardiovascular risk in women after metabolic complications in pregnancy (Q36404371) (← links)
- Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming (Q36432504) (← links)
- Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond (Q36438224) (← links)
- Impaired Flow-Mediated Dilation Before, During, and After Preeclampsia: A Systematic Review and Meta-Analysis (Q36463647) (← links)
- Angiogenic factors in preeclampsia and related disorders (Q36526596) (← links)